To further understand how PLX3397 treatment affects microglia under conditions of ATN pathology, we performed scRNA-Seq analysis on CD45 + immune cells isolated from brains of tau-seeded F+/T+ that were or were not treated with PLX chow for 1.5 months (Fig. 7a). Here, MAPT is linked to oculocutaneous albinism type 1.